Related Experiment Video
Updated: Aug 5, 2026

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
Published on: October 1, 2020
Multifocal strokes and vision loss from PDLLA filler injections
You-Jiang Tan1, Nara Sugianto1, Yanhui Li1
1Department of Neurology, National Neuroscience Institute, Singapore General Hospital Campus, Neurology ACP, Duke-NUS Medical School, Outram Road, 169608, Singapore.
Poly-D, L-lactic acid (PDLLA) dermal filler use led to multifocal strokes and vision loss. This case highlights the risk of vascular complications from PDLLA injections, emphasizing the need for physician awareness.
Area of Science:
- Neurology
- Ophthalmology
- Dermatology
Background:
- Poly-D, L-lactic acid (PDLLA) is a popular cosmetic dermal filler known for its longevity.
- Vascular complications associated with PDLLA fillers are increasingly reported.
- This study details the first reported instance of multifocal strokes linked to PDLLA cosmetic injections.
Observation:
- A patient experienced sudden bilateral vision loss post-PDLLA injections in the nasolabial and infraorbital areas.
- Ophthalmoscopy revealed retinal edema and filler material in retinal arteries.
- Brain MRI confirmed multifocal strokes and left optic nerve ischemia.
Findings:
- The patient's neurological and ophthalmological symptoms were attributed to PDLLA embolism within the intracranial arterial system.
- This case demonstrates a rare but severe vascular complication of cosmetic PDLLA filler use.
- Treatment with hyperbaric oxygen therapy resulted in partial visual recovery.
Implications:
- Physicians must be aware of potential vascular complications, including stroke and vision loss, associated with PDLLA fillers.
- Early recognition and prompt management are critical for improving outcomes in patients experiencing filler-related vascular events.
- Despite its general safety profile, the increasing use of PDLLA necessitates vigilance regarding its potential for serious adverse events.
More Related Videos
04:55A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Diabetic Retinopathy